Name | Number of supported studies | Average coverage | |
---|---|---|---|
microglial cell | 9 studies | 29% ± 9% | |
classical monocyte | 7 studies | 24% ± 7% | |
dendritic cell | 6 studies | 24% ± 7% | |
macrophage | 6 studies | 29% ± 14% | |
non-classical monocyte | 4 studies | 17% ± 2% | |
GABAergic neuron | 4 studies | 28% ± 10% | |
glutamatergic neuron | 4 studies | 32% ± 11% | |
conventional dendritic cell | 3 studies | 30% ± 11% | |
endothelial cell | 3 studies | 23% ± 8% | |
myeloid cell | 3 studies | 19% ± 2% | |
monocyte | 3 studies | 24% ± 5% | |
astrocyte | 3 studies | 26% ± 13% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 28% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 735.28 | 1442 / 1445 | 100% | 12.68 | 183 / 183 |
intestine | 100% | 1179.55 | 965 / 966 | 99% | 12.08 | 523 / 527 |
stomach | 100% | 685.08 | 358 / 359 | 99% | 12.82 | 284 / 286 |
lung | 100% | 1472.76 | 578 / 578 | 98% | 8.69 | 1134 / 1155 |
brain | 99% | 1181.26 | 2621 / 2642 | 99% | 9.67 | 695 / 705 |
breast | 100% | 1095.69 | 459 / 459 | 95% | 9.94 | 1059 / 1118 |
bladder | 100% | 883.76 | 21 / 21 | 93% | 8.43 | 470 / 504 |
kidney | 100% | 615.66 | 89 / 89 | 92% | 7.86 | 833 / 901 |
pancreas | 98% | 629.91 | 320 / 328 | 94% | 8.48 | 168 / 178 |
uterus | 100% | 1110.01 | 170 / 170 | 89% | 7.70 | 409 / 459 |
thymus | 100% | 1029.20 | 652 / 653 | 89% | 6.65 | 538 / 605 |
prostate | 100% | 822.43 | 245 / 245 | 88% | 6.20 | 442 / 502 |
ovary | 100% | 1428.82 | 180 / 180 | 86% | 4.89 | 370 / 430 |
skin | 100% | 1357.79 | 1804 / 1809 | 86% | 7.00 | 405 / 472 |
adrenal gland | 99% | 647.71 | 256 / 258 | 76% | 3.88 | 174 / 230 |
liver | 93% | 376.92 | 210 / 226 | 65% | 3.13 | 265 / 406 |
adipose | 100% | 1152.53 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1665.90 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 985.59 | 1333 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2681.02 | 922 / 929 | 0% | 0 | 0 / 0 |
muscle | 96% | 540.12 | 768 / 803 | 0% | 0 | 0 / 0 |
heart | 89% | 413.93 | 762 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 7.97 | 39 / 45 |
lymph node | 0% | 0 | 0 / 0 | 66% | 7.60 | 19 / 29 |
eye | 0% | 0 | 0 / 0 | 41% | 1.55 | 33 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007584 | Biological process | response to nutrient |
GO_0008635 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c |
GO_0070059 | Biological process | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
GO_0030900 | Biological process | forebrain development |
GO_0001822 | Biological process | kidney development |
GO_0072432 | Biological process | response to G1 DNA damage checkpoint signaling |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0097193 | Biological process | intrinsic apoptotic signaling pathway |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0030154 | Biological process | cell differentiation |
GO_0001666 | Biological process | response to hypoxia |
GO_0010659 | Biological process | cardiac muscle cell apoptotic process |
GO_0001843 | Biological process | neural tube closure |
GO_0006915 | Biological process | apoptotic process |
GO_2001235 | Biological process | positive regulation of apoptotic signaling pathway |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0007399 | Biological process | nervous system development |
GO_1902510 | Biological process | regulation of apoptotic DNA fragmentation |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0043293 | Cellular component | apoptosome |
GO_0034774 | Cellular component | secretory granule lumen |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0043531 | Molecular function | ADP binding |
GO_0008656 | Molecular function | cysteine-type endopeptidase activator activity involved in apoptotic process |
GO_0031072 | Molecular function | heat shock protein binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0000166 | Molecular function | nucleotide binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | APAF1 |
Protein name | Alternative protein APAF1 Apoptotic protease-activating factor 1 (APAF-1) Apoptotic peptidase activating factor 1 |
Synonyms | KIAA0413 |
Description | FUNCTION: Oligomeric Apaf-1 mediates the cytochrome c-dependent autocatalytic activation of pro-caspase-9 (Apaf-3), leading to the activation of caspase-3 and apoptosis. This activation requires ATP. Isoform 6 is less effective in inducing apoptosis. . FUNCTION: Oligomeric Apaf-1 mediates the cytochrome c-dependent autocatalytic activation of pro-caspase-9 (Apaf-3), leading to the activation of caspase-3 and apoptosis. This activation requires ATP. . FUNCTION: Oligomeric Apaf-1 mediates the cytochrome c-dependent autocatalytic activation of pro-caspase-9 (Apaf-3), leading to the activation of caspase-3 and apoptosis. This activation requires ATP. . |
Accessions | ENST00000547045.5 [O14727-4] O14727 ENST00000550527.5 [O14727-2] A5YM44 C9JLV4 ENST00000549007.1 ENST00000547743.1 ENST00000552268.5 [O14727-6] A7E2A2 ENST00000357310.5 [O14727-4] ENST00000333991.5 [O14727-6] ENST00000359972.6 [O14727-3] ENST00000551964.6 [O14727-1] L8E801 F8VNZ0 |